Global Contraceptive Drugs and Devices Market Research Report 2026(Status and Outlook)
A contraceptive is a device or drug that prevents a woman from becoming pregnant.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Contraceptive Drugs and Devices market size was estimated at USD 7116.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Contraceptive Drugs and Devices market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Contraceptive Drugs and Devices market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Contraceptive Drugs and Devices market.
Global Contraceptive Drugs and Devices Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
Market Segmentation (by Type)
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
Market Segmentation (by Application)
Hospitals
Pharmacies
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Contraceptive Drugs and Devices Market
Overview of the regional outlook of the Contraceptive Drugs and Devices Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Contraceptive Drugs and Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Contraceptive Drugs and Devices, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Contraceptive Drugs and Devices market size was estimated at USD 7116.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Contraceptive Drugs and Devices market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Contraceptive Drugs and Devices market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Contraceptive Drugs and Devices market.
Global Contraceptive Drugs and Devices Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
Market Segmentation (by Type)
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
Market Segmentation (by Application)
Hospitals
Pharmacies
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Contraceptive Drugs and Devices Market
Overview of the regional outlook of the Contraceptive Drugs and Devices Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Contraceptive Drugs and Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Contraceptive Drugs and Devices, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Contraceptive Drugs and Devices
1.2 Key Market Segments
1.2.1 Contraceptive Drugs and Devices Segment by Type
1.2.2 Contraceptive Drugs and Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CONTRACEPTIVE DRUGS AND DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Contraceptive Drugs and Devices Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Contraceptive Drugs and Devices Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CONTRACEPTIVE DRUGS AND DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Contraceptive Drugs and Devices Product Life Cycle
3.3 Global Contraceptive Drugs and Devices Sales by Manufacturers (2020-2025)
3.4 Global Contraceptive Drugs and Devices Revenue Market Share by Manufacturers (2020-2025)
3.5 Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Contraceptive Drugs and Devices Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Contraceptive Drugs and Devices Market Competitive Situation and Trends
3.8.1 Contraceptive Drugs and Devices Market Concentration Rate
3.8.2 Global 5 and 10 Largest Contraceptive Drugs and Devices Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CONTRACEPTIVE DRUGS AND DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Contraceptive Drugs and Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CONTRACEPTIVE DRUGS AND DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Contraceptive Drugs and Devices Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Contraceptive Drugs and Devices Market
5.7 ESG Ratings of Leading Companies
6 CONTRACEPTIVE DRUGS AND DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
6.3 Global Contraceptive Drugs and Devices Market Size by Type (2020-2025)
6.4 Global Contraceptive Drugs and Devices Price by Type (2020-2025)
7 CONTRACEPTIVE DRUGS AND DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Contraceptive Drugs and Devices Market Sales by Application (2020-2025)
7.3 Global Contraceptive Drugs and Devices Market Size (M USD) by Application (2020-2025)
7.4 Global Contraceptive Drugs and Devices Sales Growth Rate by Application (2020-2025)
8 CONTRACEPTIVE DRUGS AND DEVICES MARKET SALES BY REGION
8.1 Global Contraceptive Drugs and Devices Sales by Region
8.1.1 Global Contraceptive Drugs and Devices Sales by Region
8.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Region
8.2 Global Contraceptive Drugs and Devices Market Size by Region
8.2.1 Global Contraceptive Drugs and Devices Market Size by Region
8.2.2 Global Contraceptive Drugs and Devices Market Size by Region
8.3 North America
8.3.1 North America Contraceptive Drugs and Devices Sales by Country
8.3.2 North America Contraceptive Drugs and Devices Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Contraceptive Drugs and Devices Sales by Country
8.4.2 Europe Contraceptive Drugs and Devices Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Contraceptive Drugs and Devices Sales by Region
8.5.2 Asia Pacific Contraceptive Drugs and Devices Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Contraceptive Drugs and Devices Sales by Country
8.6.2 South America Contraceptive Drugs and Devices Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Region
8.7.2 Middle East and Africa Contraceptive Drugs and Devices Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CONTRACEPTIVE DRUGS AND DEVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Contraceptive Drugs and Devices by Region(2020-2025)
9.2 Global Contraceptive Drugs and Devices Revenue Market Share by Region (2020-2025)
9.3 Global Contraceptive Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Contraceptive Drugs and Devices Production
9.4.1 North America Contraceptive Drugs and Devices Production Growth Rate (2020-2025)
9.4.2 North America Contraceptive Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Contraceptive Drugs and Devices Production
9.5.1 Europe Contraceptive Drugs and Devices Production Growth Rate (2020-2025)
9.5.2 Europe Contraceptive Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Contraceptive Drugs and Devices Production (2020-2025)
9.6.1 Japan Contraceptive Drugs and Devices Production Growth Rate (2020-2025)
9.6.2 Japan Contraceptive Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Contraceptive Drugs and Devices Production (2020-2025)
9.7.1 China Contraceptive Drugs and Devices Production Growth Rate (2020-2025)
9.7.2 China Contraceptive Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer Healthcare
10.1.1 Bayer Healthcare Basic Information
10.1.2 Bayer Healthcare Contraceptive Drugs and Devices Product Overview
10.1.3 Bayer Healthcare Contraceptive Drugs and Devices Product Market Performance
10.1.4 Bayer Healthcare Business Overview
10.1.5 Bayer Healthcare SWOT Analysis
10.1.6 Bayer Healthcare Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Contraceptive Drugs and Devices Product Overview
10.2.3 Merck Contraceptive Drugs and Devices Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Church and Dwight
10.3.1 Church and Dwight Basic Information
10.3.2 Church and Dwight Contraceptive Drugs and Devices Product Overview
10.3.3 Church and Dwight Contraceptive Drugs and Devices Product Market Performance
10.3.4 Church and Dwight Business Overview
10.3.5 Church and Dwight SWOT Analysis
10.3.6 Church and Dwight Recent Developments
10.4 Warmer Chilcott
10.4.1 Warmer Chilcott Basic Information
10.4.2 Warmer Chilcott Contraceptive Drugs and Devices Product Overview
10.4.3 Warmer Chilcott Contraceptive Drugs and Devices Product Market Performance
10.4.4 Warmer Chilcott Business Overview
10.4.5 Warmer Chilcott Recent Developments
10.5 Agile Therapeutics
10.5.1 Agile Therapeutics Basic Information
10.5.2 Agile Therapeutics Contraceptive Drugs and Devices Product Overview
10.5.3 Agile Therapeutics Contraceptive Drugs and Devices Product Market Performance
10.5.4 Agile Therapeutics Business Overview
10.5.5 Agile Therapeutics Recent Developments
10.6 Pfizer
10.6.1 Pfizer Basic Information
10.6.2 Pfizer Contraceptive Drugs and Devices Product Overview
10.6.3 Pfizer Contraceptive Drugs and Devices Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 BioSante Pharmaceuticals
10.7.1 BioSante Pharmaceuticals Basic Information
10.7.2 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Overview
10.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Market Performance
10.7.4 BioSante Pharmaceuticals Business Overview
10.7.5 BioSante Pharmaceuticals Recent Developments
10.8 Mayer Laboratories
10.8.1 Mayer Laboratories Basic Information
10.8.2 Mayer Laboratories Contraceptive Drugs and Devices Product Overview
10.8.3 Mayer Laboratories Contraceptive Drugs and Devices Product Market Performance
10.8.4 Mayer Laboratories Business Overview
10.8.5 Mayer Laboratories Recent Developments
10.9 Pantarhei Bioscience
10.9.1 Pantarhei Bioscience Basic Information
10.9.2 Pantarhei Bioscience Contraceptive Drugs and Devices Product Overview
10.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Product Market Performance
10.9.4 Pantarhei Bioscience Business Overview
10.9.5 Pantarhei Bioscience Recent Developments
10.10 Teva Pharmaceutical Industries
10.10.1 Teva Pharmaceutical Industries Basic Information
10.10.2 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Overview
10.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Market Performance
10.10.4 Teva Pharmaceutical Industries Business Overview
10.10.5 Teva Pharmaceutical Industries Recent Developments
11 CONTRACEPTIVE DRUGS AND DEVICES MARKET FORECAST BY REGION
11.1 Global Contraceptive Drugs and Devices Market Size Forecast
11.2 Global Contraceptive Drugs and Devices Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Contraceptive Drugs and Devices Market Size Forecast by Country
11.2.3 Asia Pacific Contraceptive Drugs and Devices Market Size Forecast by Region
11.2.4 South America Contraceptive Drugs and Devices Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Contraceptive Drugs and Devices by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Contraceptive Drugs and Devices Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Contraceptive Drugs and Devices by Type (2026-2035)
12.1.2 Global Contraceptive Drugs and Devices Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Contraceptive Drugs and Devices by Type (2026-2035)
12.2 Global Contraceptive Drugs and Devices Market Forecast by Application (2026-2035)
12.2.1 Global Contraceptive Drugs and Devices Sales (K MT) Forecast by Application
12.2.2 Global Contraceptive Drugs and Devices Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Contraceptive Drugs and Devices
1.2 Key Market Segments
1.2.1 Contraceptive Drugs and Devices Segment by Type
1.2.2 Contraceptive Drugs and Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CONTRACEPTIVE DRUGS AND DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Contraceptive Drugs and Devices Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Contraceptive Drugs and Devices Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CONTRACEPTIVE DRUGS AND DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Contraceptive Drugs and Devices Product Life Cycle
3.3 Global Contraceptive Drugs and Devices Sales by Manufacturers (2020-2025)
3.4 Global Contraceptive Drugs and Devices Revenue Market Share by Manufacturers (2020-2025)
3.5 Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Contraceptive Drugs and Devices Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Contraceptive Drugs and Devices Market Competitive Situation and Trends
3.8.1 Contraceptive Drugs and Devices Market Concentration Rate
3.8.2 Global 5 and 10 Largest Contraceptive Drugs and Devices Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CONTRACEPTIVE DRUGS AND DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Contraceptive Drugs and Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CONTRACEPTIVE DRUGS AND DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Contraceptive Drugs and Devices Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Contraceptive Drugs and Devices Market
5.7 ESG Ratings of Leading Companies
6 CONTRACEPTIVE DRUGS AND DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
6.3 Global Contraceptive Drugs and Devices Market Size by Type (2020-2025)
6.4 Global Contraceptive Drugs and Devices Price by Type (2020-2025)
7 CONTRACEPTIVE DRUGS AND DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Contraceptive Drugs and Devices Market Sales by Application (2020-2025)
7.3 Global Contraceptive Drugs and Devices Market Size (M USD) by Application (2020-2025)
7.4 Global Contraceptive Drugs and Devices Sales Growth Rate by Application (2020-2025)
8 CONTRACEPTIVE DRUGS AND DEVICES MARKET SALES BY REGION
8.1 Global Contraceptive Drugs and Devices Sales by Region
8.1.1 Global Contraceptive Drugs and Devices Sales by Region
8.1.2 Global Contraceptive Drugs and Devices Sales Market Share by Region
8.2 Global Contraceptive Drugs and Devices Market Size by Region
8.2.1 Global Contraceptive Drugs and Devices Market Size by Region
8.2.2 Global Contraceptive Drugs and Devices Market Size by Region
8.3 North America
8.3.1 North America Contraceptive Drugs and Devices Sales by Country
8.3.2 North America Contraceptive Drugs and Devices Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Contraceptive Drugs and Devices Sales by Country
8.4.2 Europe Contraceptive Drugs and Devices Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Contraceptive Drugs and Devices Sales by Region
8.5.2 Asia Pacific Contraceptive Drugs and Devices Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Contraceptive Drugs and Devices Sales by Country
8.6.2 South America Contraceptive Drugs and Devices Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Region
8.7.2 Middle East and Africa Contraceptive Drugs and Devices Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CONTRACEPTIVE DRUGS AND DEVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Contraceptive Drugs and Devices by Region(2020-2025)
9.2 Global Contraceptive Drugs and Devices Revenue Market Share by Region (2020-2025)
9.3 Global Contraceptive Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Contraceptive Drugs and Devices Production
9.4.1 North America Contraceptive Drugs and Devices Production Growth Rate (2020-2025)
9.4.2 North America Contraceptive Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Contraceptive Drugs and Devices Production
9.5.1 Europe Contraceptive Drugs and Devices Production Growth Rate (2020-2025)
9.5.2 Europe Contraceptive Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Contraceptive Drugs and Devices Production (2020-2025)
9.6.1 Japan Contraceptive Drugs and Devices Production Growth Rate (2020-2025)
9.6.2 Japan Contraceptive Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Contraceptive Drugs and Devices Production (2020-2025)
9.7.1 China Contraceptive Drugs and Devices Production Growth Rate (2020-2025)
9.7.2 China Contraceptive Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Bayer Healthcare
10.1.1 Bayer Healthcare Basic Information
10.1.2 Bayer Healthcare Contraceptive Drugs and Devices Product Overview
10.1.3 Bayer Healthcare Contraceptive Drugs and Devices Product Market Performance
10.1.4 Bayer Healthcare Business Overview
10.1.5 Bayer Healthcare SWOT Analysis
10.1.6 Bayer Healthcare Recent Developments
10.2 Merck
10.2.1 Merck Basic Information
10.2.2 Merck Contraceptive Drugs and Devices Product Overview
10.2.3 Merck Contraceptive Drugs and Devices Product Market Performance
10.2.4 Merck Business Overview
10.2.5 Merck SWOT Analysis
10.2.6 Merck Recent Developments
10.3 Church and Dwight
10.3.1 Church and Dwight Basic Information
10.3.2 Church and Dwight Contraceptive Drugs and Devices Product Overview
10.3.3 Church and Dwight Contraceptive Drugs and Devices Product Market Performance
10.3.4 Church and Dwight Business Overview
10.3.5 Church and Dwight SWOT Analysis
10.3.6 Church and Dwight Recent Developments
10.4 Warmer Chilcott
10.4.1 Warmer Chilcott Basic Information
10.4.2 Warmer Chilcott Contraceptive Drugs and Devices Product Overview
10.4.3 Warmer Chilcott Contraceptive Drugs and Devices Product Market Performance
10.4.4 Warmer Chilcott Business Overview
10.4.5 Warmer Chilcott Recent Developments
10.5 Agile Therapeutics
10.5.1 Agile Therapeutics Basic Information
10.5.2 Agile Therapeutics Contraceptive Drugs and Devices Product Overview
10.5.3 Agile Therapeutics Contraceptive Drugs and Devices Product Market Performance
10.5.4 Agile Therapeutics Business Overview
10.5.5 Agile Therapeutics Recent Developments
10.6 Pfizer
10.6.1 Pfizer Basic Information
10.6.2 Pfizer Contraceptive Drugs and Devices Product Overview
10.6.3 Pfizer Contraceptive Drugs and Devices Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 BioSante Pharmaceuticals
10.7.1 BioSante Pharmaceuticals Basic Information
10.7.2 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Overview
10.7.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Market Performance
10.7.4 BioSante Pharmaceuticals Business Overview
10.7.5 BioSante Pharmaceuticals Recent Developments
10.8 Mayer Laboratories
10.8.1 Mayer Laboratories Basic Information
10.8.2 Mayer Laboratories Contraceptive Drugs and Devices Product Overview
10.8.3 Mayer Laboratories Contraceptive Drugs and Devices Product Market Performance
10.8.4 Mayer Laboratories Business Overview
10.8.5 Mayer Laboratories Recent Developments
10.9 Pantarhei Bioscience
10.9.1 Pantarhei Bioscience Basic Information
10.9.2 Pantarhei Bioscience Contraceptive Drugs and Devices Product Overview
10.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Product Market Performance
10.9.4 Pantarhei Bioscience Business Overview
10.9.5 Pantarhei Bioscience Recent Developments
10.10 Teva Pharmaceutical Industries
10.10.1 Teva Pharmaceutical Industries Basic Information
10.10.2 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Overview
10.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Market Performance
10.10.4 Teva Pharmaceutical Industries Business Overview
10.10.5 Teva Pharmaceutical Industries Recent Developments
11 CONTRACEPTIVE DRUGS AND DEVICES MARKET FORECAST BY REGION
11.1 Global Contraceptive Drugs and Devices Market Size Forecast
11.2 Global Contraceptive Drugs and Devices Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Contraceptive Drugs and Devices Market Size Forecast by Country
11.2.3 Asia Pacific Contraceptive Drugs and Devices Market Size Forecast by Region
11.2.4 South America Contraceptive Drugs and Devices Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Contraceptive Drugs and Devices by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Contraceptive Drugs and Devices Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Contraceptive Drugs and Devices by Type (2026-2035)
12.1.2 Global Contraceptive Drugs and Devices Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Contraceptive Drugs and Devices by Type (2026-2035)
12.2 Global Contraceptive Drugs and Devices Market Forecast by Application (2026-2035)
12.2.1 Global Contraceptive Drugs and Devices Sales (K MT) Forecast by Application
12.2.2 Global Contraceptive Drugs and Devices Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Contraceptive Drugs and Devices Market Size by Type (M USD)
Table 4. Global Contraceptive Drugs and Devices Market Size by Application
Table 5. Contraceptive Drugs and Devices Market Size Comparison by Region (M USD)
Table 6. Global Contraceptive Drugs and Devices Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Contraceptive Drugs and Devices Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Contraceptive Drugs and Devices Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptive Drugs and Devices as of 2025)
Table 11. Global Market Contraceptive Drugs and Devices Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Contraceptive Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Contraceptive Drugs and Devices Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Contraceptive Drugs and Devices Sales by Type (K MT)
Table 27. Global Contraceptive Drugs and Devices Market Size by Type (M USD)
Table 28. Global Contraceptive Drugs and Devices Sales (K MT) by Type (2020-2025)
Table 29. Global Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Table 30. Global Contraceptive Drugs and Devices Market Size (M USD) by Type (2020-2025)
Table 31. Global Contraceptive Drugs and Devices Market Share by Type (2020-2025)
Table 32. Global Contraceptive Drugs and Devices Price (USD/KG) by Type (2020-2025)
Table 33. Global Contraceptive Drugs and Devices Sales (K MT) by Application
Table 34. Global Contraceptive Drugs and Devices Market Size by Application
Table 35. Global Contraceptive Drugs and Devices Sales by Application (2020-2025) & (K MT)
Table 36. Global Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Table 37. Global Contraceptive Drugs and Devices Market Size by Application (2020-2025) & (M USD)
Table 38. Global Contraceptive Drugs and Devices Market Share by Application (2020-2025)
Table 39. Global Contraceptive Drugs and Devices Sales Growth Rate by Application (2020-2025)
Table 40. Global Contraceptive Drugs and Devices Sales by Region (2020-2025) & (K MT)
Table 41. Global Contraceptive Drugs and Devices Sales Market Share by Region (2020-2025)
Table 42. Global Contraceptive Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 43. Global Contraceptive Drugs and Devices Market Size by Region (2020-2025)
Table 44. North America Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K MT)
Table 45. North America Contraceptive Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K MT)
Table 47. Europe Contraceptive Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Contraceptive Drugs and Devices Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Contraceptive Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 50. South America Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K MT)
Table 51. South America Contraceptive Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Contraceptive Drugs and Devices Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Contraceptive Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 54. Global Contraceptive Drugs and Devices Production (K MT) by Region(2020-2025)
Table 55. Global Contraceptive Drugs and Devices Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2020-2025)
Table 57. Global Contraceptive Drugs and Devices Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Contraceptive Drugs and Devices Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Contraceptive Drugs and Devices Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Contraceptive Drugs and Devices Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Contraceptive Drugs and Devices Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Healthcare Basic Information
Table 63. Bayer Healthcare Contraceptive Drugs and Devices Product Overview
Table 64. Bayer Healthcare Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Healthcare Business Overview
Table 66. Bayer Healthcare SWOT Analysis
Table 67. Bayer Healthcare Recent Developments
Table 68. Merck Basic Information
Table 69. Merck Contraceptive Drugs and Devices Product Overview
Table 70. Merck Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck Business Overview
Table 72. Merck SWOT Analysis
Table 73. Merck Recent Developments
Table 74. Church and Dwight Basic Information
Table 75. Church and Dwight Contraceptive Drugs and Devices Product Overview
Table 76. Church and Dwight Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Church and Dwight Business Overview
Table 78. Church and Dwight SWOT Analysis
Table 79. Church and Dwight Recent Developments
Table 80. Warmer Chilcott Basic Information
Table 81. Warmer Chilcott Contraceptive Drugs and Devices Product Overview
Table 82. Warmer Chilcott Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Warmer Chilcott Business Overview
Table 84. Warmer Chilcott Recent Developments
Table 85. Agile Therapeutics Basic Information
Table 86. Agile Therapeutics Contraceptive Drugs and Devices Product Overview
Table 87. Agile Therapeutics Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Agile Therapeutics Business Overview
Table 89. Agile Therapeutics Recent Developments
Table 90. Pfizer Basic Information
Table 91. Pfizer Contraceptive Drugs and Devices Product Overview
Table 92. Pfizer Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Pfizer Business Overview
Table 94. Pfizer Recent Developments
Table 95. BioSante Pharmaceuticals Basic Information
Table 96. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Overview
Table 97. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. BioSante Pharmaceuticals Business Overview
Table 99. BioSante Pharmaceuticals Recent Developments
Table 100. Mayer Laboratories Basic Information
Table 101. Mayer Laboratories Contraceptive Drugs and Devices Product Overview
Table 102. Mayer Laboratories Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Mayer Laboratories Business Overview
Table 104. Mayer Laboratories Recent Developments
Table 105. Pantarhei Bioscience Basic Information
Table 106. Pantarhei Bioscience Contraceptive Drugs and Devices Product Overview
Table 107. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Pantarhei Bioscience Business Overview
Table 109. Pantarhei Bioscience Recent Developments
Table 110. Teva Pharmaceutical Industries Basic Information
Table 111. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Overview
Table 112. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Teva Pharmaceutical Industries Business Overview
Table 114. Teva Pharmaceutical Industries Recent Developments
Table 115. Global Contraceptive Drugs and Devices Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Contraceptive Drugs and Devices Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Contraceptive Drugs and Devices Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Contraceptive Drugs and Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Contraceptive Drugs and Devices Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Contraceptive Drugs and Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Contraceptive Drugs and Devices Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Contraceptive Drugs and Devices Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Contraceptive Drugs and Devices Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Contraceptive Drugs and Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Contraceptive Drugs and Devices Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Contraceptive Drugs and Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Contraceptive Drugs and Devices Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Contraceptive Drugs and Devices Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Contraceptive Drugs and Devices Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Contraceptive Drugs and Devices Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Contraceptive Drugs and Devices Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Contraceptive Drugs and Devices Market Size by Type (M USD)
Table 4. Global Contraceptive Drugs and Devices Market Size by Application
Table 5. Contraceptive Drugs and Devices Market Size Comparison by Region (M USD)
Table 6. Global Contraceptive Drugs and Devices Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Contraceptive Drugs and Devices Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Contraceptive Drugs and Devices Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptive Drugs and Devices as of 2025)
Table 11. Global Market Contraceptive Drugs and Devices Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Contraceptive Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Contraceptive Drugs and Devices Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Contraceptive Drugs and Devices Sales by Type (K MT)
Table 27. Global Contraceptive Drugs and Devices Market Size by Type (M USD)
Table 28. Global Contraceptive Drugs and Devices Sales (K MT) by Type (2020-2025)
Table 29. Global Contraceptive Drugs and Devices Sales Market Share by Type (2020-2025)
Table 30. Global Contraceptive Drugs and Devices Market Size (M USD) by Type (2020-2025)
Table 31. Global Contraceptive Drugs and Devices Market Share by Type (2020-2025)
Table 32. Global Contraceptive Drugs and Devices Price (USD/KG) by Type (2020-2025)
Table 33. Global Contraceptive Drugs and Devices Sales (K MT) by Application
Table 34. Global Contraceptive Drugs and Devices Market Size by Application
Table 35. Global Contraceptive Drugs and Devices Sales by Application (2020-2025) & (K MT)
Table 36. Global Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Table 37. Global Contraceptive Drugs and Devices Market Size by Application (2020-2025) & (M USD)
Table 38. Global Contraceptive Drugs and Devices Market Share by Application (2020-2025)
Table 39. Global Contraceptive Drugs and Devices Sales Growth Rate by Application (2020-2025)
Table 40. Global Contraceptive Drugs and Devices Sales by Region (2020-2025) & (K MT)
Table 41. Global Contraceptive Drugs and Devices Sales Market Share by Region (2020-2025)
Table 42. Global Contraceptive Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 43. Global Contraceptive Drugs and Devices Market Size by Region (2020-2025)
Table 44. North America Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K MT)
Table 45. North America Contraceptive Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K MT)
Table 47. Europe Contraceptive Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Contraceptive Drugs and Devices Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Contraceptive Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 50. South America Contraceptive Drugs and Devices Sales by Country (2020-2025) & (K MT)
Table 51. South America Contraceptive Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Contraceptive Drugs and Devices Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Contraceptive Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 54. Global Contraceptive Drugs and Devices Production (K MT) by Region(2020-2025)
Table 55. Global Contraceptive Drugs and Devices Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2020-2025)
Table 57. Global Contraceptive Drugs and Devices Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Contraceptive Drugs and Devices Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Contraceptive Drugs and Devices Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Contraceptive Drugs and Devices Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Contraceptive Drugs and Devices Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Bayer Healthcare Basic Information
Table 63. Bayer Healthcare Contraceptive Drugs and Devices Product Overview
Table 64. Bayer Healthcare Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Bayer Healthcare Business Overview
Table 66. Bayer Healthcare SWOT Analysis
Table 67. Bayer Healthcare Recent Developments
Table 68. Merck Basic Information
Table 69. Merck Contraceptive Drugs and Devices Product Overview
Table 70. Merck Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck Business Overview
Table 72. Merck SWOT Analysis
Table 73. Merck Recent Developments
Table 74. Church and Dwight Basic Information
Table 75. Church and Dwight Contraceptive Drugs and Devices Product Overview
Table 76. Church and Dwight Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Church and Dwight Business Overview
Table 78. Church and Dwight SWOT Analysis
Table 79. Church and Dwight Recent Developments
Table 80. Warmer Chilcott Basic Information
Table 81. Warmer Chilcott Contraceptive Drugs and Devices Product Overview
Table 82. Warmer Chilcott Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Warmer Chilcott Business Overview
Table 84. Warmer Chilcott Recent Developments
Table 85. Agile Therapeutics Basic Information
Table 86. Agile Therapeutics Contraceptive Drugs and Devices Product Overview
Table 87. Agile Therapeutics Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Agile Therapeutics Business Overview
Table 89. Agile Therapeutics Recent Developments
Table 90. Pfizer Basic Information
Table 91. Pfizer Contraceptive Drugs and Devices Product Overview
Table 92. Pfizer Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Pfizer Business Overview
Table 94. Pfizer Recent Developments
Table 95. BioSante Pharmaceuticals Basic Information
Table 96. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Overview
Table 97. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. BioSante Pharmaceuticals Business Overview
Table 99. BioSante Pharmaceuticals Recent Developments
Table 100. Mayer Laboratories Basic Information
Table 101. Mayer Laboratories Contraceptive Drugs and Devices Product Overview
Table 102. Mayer Laboratories Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Mayer Laboratories Business Overview
Table 104. Mayer Laboratories Recent Developments
Table 105. Pantarhei Bioscience Basic Information
Table 106. Pantarhei Bioscience Contraceptive Drugs and Devices Product Overview
Table 107. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Pantarhei Bioscience Business Overview
Table 109. Pantarhei Bioscience Recent Developments
Table 110. Teva Pharmaceutical Industries Basic Information
Table 111. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Overview
Table 112. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Teva Pharmaceutical Industries Business Overview
Table 114. Teva Pharmaceutical Industries Recent Developments
Table 115. Global Contraceptive Drugs and Devices Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global Contraceptive Drugs and Devices Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America Contraceptive Drugs and Devices Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America Contraceptive Drugs and Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe Contraceptive Drugs and Devices Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe Contraceptive Drugs and Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific Contraceptive Drugs and Devices Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific Contraceptive Drugs and Devices Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America Contraceptive Drugs and Devices Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America Contraceptive Drugs and Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa Contraceptive Drugs and Devices Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa Contraceptive Drugs and Devices Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global Contraceptive Drugs and Devices Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global Contraceptive Drugs and Devices Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global Contraceptive Drugs and Devices Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global Contraceptive Drugs and Devices Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global Contraceptive Drugs and Devices Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Contraceptive Drugs and Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Contraceptive Drugs and Devices Market Size (M USD), 2025-2035
Figure 5. Global Contraceptive Drugs and Devices Market Size (M USD) (2020-2035)
Figure 6. Global Contraceptive Drugs and Devices Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Contraceptive Drugs and Devices Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Contraceptive Drugs and Devices Product Life Cycle
Figure 13. Contraceptive Drugs and Devices Sales Share by Manufacturers in 2025
Figure 14. Global Contraceptive Drugs and Devices Revenue Share by Manufacturers in 2025
Figure 15. Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Contraceptive Drugs and Devices Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Contraceptive Drugs and Devices Revenue in 2025
Figure 18. Industry Chain Map of Contraceptive Drugs and Devices
Figure 19. Global Contraceptive Drugs and Devices Market PEST Analysis
Figure 20. Global Contraceptive Drugs and Devices Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Contraceptive Drugs and Devices Market Share by Type
Figure 27. Sales Market Share of Contraceptive Drugs and Devices by Type (2020-2025)
Figure 28. Sales Market Share of Contraceptive Drugs and Devices by Type in 2025
Figure 29. Market Share of Contraceptive Drugs and Devices by Type (2020-2025)
Figure 30. Market Share of Contraceptive Drugs and Devices by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Contraceptive Drugs and Devices Market Share by Application
Figure 33. Global Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 34. Global Contraceptive Drugs and Devices Sales Market Share by Application in 2025
Figure 35. Global Contraceptive Drugs and Devices Market Share by Application (2020-2025)
Figure 36. Global Contraceptive Drugs and Devices Market Share by Application in 2025
Figure 37. Global Contraceptive Drugs and Devices Sales Growth Rate by Application (2020-2025)
Figure 38. Global Contraceptive Drugs and Devices Sales Market Share by Region (2020-2025)
Figure 39. Global Contraceptive Drugs and Devices Market Size by Region (2020-2025)
Figure 40. North America Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Contraceptive Drugs and Devices Sales Market Share by Country in 2024
Figure 43. North America Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Contraceptive Drugs and Devices Market Size by Country in 2024
Figure 45. U.S. Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Contraceptive Drugs and Devices Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Contraceptive Drugs and Devices Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Contraceptive Drugs and Devices Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Contraceptive Drugs and Devices Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Contraceptive Drugs and Devices Sales Market Share by Country in 2024
Figure 53. Europe Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Contraceptive Drugs and Devices Market Size by Country in 2024
Figure 55. Germany Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Contraceptive Drugs and Devices Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Region in 2024
Figure 67. Asia Pacific Contraceptive Drugs and Devices Market Size by Region in 2024
Figure 68. China Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Contraceptive Drugs and Devices Sales and Growth Rate (K MT)
Figure 79. South America Contraceptive Drugs and Devices Sales Market Share by Country in 2024
Figure 80. South America Contraceptive Drugs and Devices Market Size and Growth Rate (M USD)
Figure 81. South America Contraceptive Drugs and Devices Market Size by Country in 2024
Figure 82. Brazil Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Contraceptive Drugs and Devices Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Contraceptive Drugs and Devices Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Contraceptive Drugs and Devices Market Size by Region in 2024
Figure 92. Saudi Arabia Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Contraceptive Drugs and Devices Production Market Share by Region (2020-2025)
Figure 103. North America Contraceptive Drugs and Devices Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Contraceptive Drugs and Devices Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Contraceptive Drugs and Devices Production (K MT) Growth Rate (2020-2025)
Figure 106. China Contraceptive Drugs and Devices Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Contraceptive Drugs and Devices Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Contraceptive Drugs and Devices Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Contraceptive Drugs and Devices Market Share Forecast by Type (2026-2035)
Figure 111. Global Contraceptive Drugs and Devices Sales Forecast by Application (2026-2035)
Figure 112. Global Contraceptive Drugs and Devices Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Contraceptive Drugs and Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Contraceptive Drugs and Devices Market Size (M USD), 2025-2035
Figure 5. Global Contraceptive Drugs and Devices Market Size (M USD) (2020-2035)
Figure 6. Global Contraceptive Drugs and Devices Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Contraceptive Drugs and Devices Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Contraceptive Drugs and Devices Product Life Cycle
Figure 13. Contraceptive Drugs and Devices Sales Share by Manufacturers in 2025
Figure 14. Global Contraceptive Drugs and Devices Revenue Share by Manufacturers in 2025
Figure 15. Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Contraceptive Drugs and Devices Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Contraceptive Drugs and Devices Revenue in 2025
Figure 18. Industry Chain Map of Contraceptive Drugs and Devices
Figure 19. Global Contraceptive Drugs and Devices Market PEST Analysis
Figure 20. Global Contraceptive Drugs and Devices Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Contraceptive Drugs and Devices Market Share by Type
Figure 27. Sales Market Share of Contraceptive Drugs and Devices by Type (2020-2025)
Figure 28. Sales Market Share of Contraceptive Drugs and Devices by Type in 2025
Figure 29. Market Share of Contraceptive Drugs and Devices by Type (2020-2025)
Figure 30. Market Share of Contraceptive Drugs and Devices by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Contraceptive Drugs and Devices Market Share by Application
Figure 33. Global Contraceptive Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 34. Global Contraceptive Drugs and Devices Sales Market Share by Application in 2025
Figure 35. Global Contraceptive Drugs and Devices Market Share by Application (2020-2025)
Figure 36. Global Contraceptive Drugs and Devices Market Share by Application in 2025
Figure 37. Global Contraceptive Drugs and Devices Sales Growth Rate by Application (2020-2025)
Figure 38. Global Contraceptive Drugs and Devices Sales Market Share by Region (2020-2025)
Figure 39. Global Contraceptive Drugs and Devices Market Size by Region (2020-2025)
Figure 40. North America Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Contraceptive Drugs and Devices Sales Market Share by Country in 2024
Figure 43. North America Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Contraceptive Drugs and Devices Market Size by Country in 2024
Figure 45. U.S. Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Contraceptive Drugs and Devices Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Contraceptive Drugs and Devices Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Contraceptive Drugs and Devices Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Contraceptive Drugs and Devices Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Contraceptive Drugs and Devices Sales Market Share by Country in 2024
Figure 53. Europe Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Contraceptive Drugs and Devices Market Size by Country in 2024
Figure 55. Germany Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Contraceptive Drugs and Devices Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Region in 2024
Figure 67. Asia Pacific Contraceptive Drugs and Devices Market Size by Region in 2024
Figure 68. China Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Contraceptive Drugs and Devices Sales and Growth Rate (K MT)
Figure 79. South America Contraceptive Drugs and Devices Sales Market Share by Country in 2024
Figure 80. South America Contraceptive Drugs and Devices Market Size and Growth Rate (M USD)
Figure 81. South America Contraceptive Drugs and Devices Market Size by Country in 2024
Figure 82. Brazil Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Contraceptive Drugs and Devices Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Contraceptive Drugs and Devices Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Contraceptive Drugs and Devices Market Size by Region in 2024
Figure 92. Saudi Arabia Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Contraceptive Drugs and Devices Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Contraceptive Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Contraceptive Drugs and Devices Production Market Share by Region (2020-2025)
Figure 103. North America Contraceptive Drugs and Devices Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Contraceptive Drugs and Devices Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Contraceptive Drugs and Devices Production (K MT) Growth Rate (2020-2025)
Figure 106. China Contraceptive Drugs and Devices Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Contraceptive Drugs and Devices Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Contraceptive Drugs and Devices Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Contraceptive Drugs and Devices Market Share Forecast by Type (2026-2035)
Figure 111. Global Contraceptive Drugs and Devices Sales Forecast by Application (2026-2035)
Figure 112. Global Contraceptive Drugs and Devices Market Share Forecast by Application (2026-2035)
